Nura Bio Announces publication of “Structural and Mechanistic Regulation of the Prodegenerative NAD Hydrolase SARM1” in CELL REPORTS

Nura Bio Launches to Discover and Develop Neuroprotective Drugs, Backed by $73 Million Series A Financing